Skip to main content
Screener/Healthcare/Biotechnology

TRDA — Entrada Therapeutics, Inc.

NASDAQ
$6.92 (—)
Micro CapUnder $10Healthcare
$5.02
$16.45
—
—
EPS (TTM)$-4.00
P/E Ratio-3.71
Dividend Yield—
Market Cap$274.1M
Volume—
Prev Close$7.05
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$875K-$39.7M$-0.950.0%-4539.1%
Q4 '25$1.3M-$39.2M$-0.9531.8%-3014.9%
Q3 '25$1.6M-$44.1M$-1.06-2276.8%-2734.4%
Q2 '25$1.9M-$43.1M$-1.04100.0%-2210.4%
Q1 '25$20.6M-$17.3M$-0.42100.0%-84.4%
Q4 '24$37.4M$1.1M$0.03100.0%3.0%
Q3 '24$19.6M-$14.0M$-0.35100.0%-71.7%
Q2 '24$94.7M$55.0M$1.55100.0%58.1%
Get Your Daily Market Recap